The seminars and meetings listed below are open to professionals and colleagues of NeuRA staff.
UPDATE: THIS EVENT HAS BEEN CANCELLED.
Join speakers from Neuroscience Research Australia (NeuRA), who will discuss the latest research in pain and the link with the brain.
New research shows that there are changes in the brain when someone has pain for a long time. Using this knowledge of the brain and how it changes with pain, researchers have developed new treatments for chronic low back pain that target how the brain and central nervous system process sensory information to produce pain. The seminar will include the latest findings and treatments aiming to reduce low back pain by targeting the brain, specifically for those with chronic back pain.
Associate Professor James McAuley – Senior Research Scientist
Edel O’Hagan – Physiotherapist and Scientist
Myths about low back pain
Matthew Bagg – Physiotherapist and Scientist
Pain, the brain and the back
Aidan Cashin – Exercise Physiologist and Scientist
Moving forward with back pain
The NeuRA PhD Completion Seminar series provides an opportunity to hear from completing PhD students and celebrate their success.
|20th Feb||Sophie Carter||Prof Danny Eckert||Novel respiratory phenotyping to determine the effects of zopiclone on obstructive sleep apnoea|
|20th Feb||Harrison Finn||A/Prof Janet Taylor||Sensory feedback during exercise contributes to fatigue by inhibiting the nervous system|
|6th Mar||Muntaseer Mahfuz||A/Prof Americo Migliaccio||Examining Vestibulo-Ocular Reflex Plasticity Using Incremental Adaptation Training|
|6th Mar||Christin Weissleder||Prof Cyndi Shannon Weickert||TBA|
|29th May||Samantha Owens||Prof Cyndi Shannon Weickert||TBA|
|29th May||David Lloyd||Prof Cyndi Shannon Weickert||TBA|
Location: John and Betty Lynch Seminar Room, Level 3, NeuRA, followed by a celebratory lunch in the cafe.
Join us for the 14th GeneMappers Conference on the 20-22nd November 2019!
The 2019 GeneMappers meeting will be a very special event, being the 20th anniversary of the first meeting which was held in Thredbo, New South Wales in 1999. Thus the meeting is returning to New South Wales this year, with a beautiful venue on Sydney harbour foreshore in Manly, around 30 minutes from Sydney City, and an attractive historic site.
While we finalise the 2019 conference website, please refer to last year’s conference website here for what happened in 2018!
Venue: Q station, Sydney Harbour National Park, Manly, NSW
2019 CONFERENCE THEMES
Analysis of rare variants, Mendelian traits and families
Gene expression & functional genomics
Translation into clinical practice
Cathryn Lewis, King’s College London, UK
|Cathryn Lewis is Professor of Genetic Epidemiology & Statistics at King’s College London, where she leads the Statistical Genetics Unit. Her academic training is in mathematics and statistics, and she has been involved in genetic studies since her PhD. She co-chairs the Psychiatric Genomics Consortium Major Depressive Disorder Working group, and leads the NIHR Maudsley BRC Biomarkers and Genomics theme. Her multi-disciplinary research group identifies and characterises genetic variants conferring risk of disease, including depression, schizophrenia, and stroke. A major focus is risk assessment, determining how the polygenic component of mental health disorders can be measured accurately and communicated effectively.|
|Mike Boehnke, University of Michigan, USA
Michael Boehnke is the Richard G. Cornell Distinguished University Professor of Biostatistics and Director of the University of Michigan Center for Statistical Genetics and Genome Science Training Program. Dr. Boehnke’s research focuses on problems of study design and statistical analysis of human genetic data with a particular emphasis on development and application of statistical methods for human gene mapping, with a current focus on disease and trait association studies based on genome sequence and genotype-array data. He is principal investigator of the Finland-United States Investigation of NIDDM (FUSION) study of the genetics of type 2 diabetes, the GoT2D and T2D-GENES type 2 diabetes sequencing studies, and the BRIDGES and InPSYght sequencing studies of bipolar disorder and schizophrenia.
|Cornelia van Duijn, University of Oxford, UK||
Cornelia M van Duijn is Professor of Epidemiology at the Nuffield Department of Population Health at The University of Oxford, UK. She is based at the Oxford Big Data Institute where she integrates large-scale (epi)genetic, transcriptomic, proteomic, metabolomic and microbiome data of epidemiological cohorts with that of brain imaging and cellular models. Cornelia’s research focuses on brain and ocular diseases such as Alzheimer disease and glaucoma but her interest spans systemic vascular, endocrine and gastrointestinal pathology that is relevant for brain and ocular function. Before moving to Oxford, Cornelia was head of Genetic Epidemiology of the Erasmus University Medical Centre and director of the international education and training program in genetic epidemiology. In 2016, she was co-appointed at the Leiden Academic Center for Drug Research (LACDR) as a Professor of Translational Epidemiology.
|Stephen Leslie, Murdoch Childrens Research Institute, Melb
Associate Professor Stephen Leslie is a statistician working in the field of mathematical genetics. He obtained his doctorate from the Department of Statistics, University of Oxford in 2008. After graduating Stephen was a post-doctoral researcher in the Department of Statistics at Oxford. He was awarded one of Oxford’s prestigious Nuffield Department of Medicine Scientific Leadership Fellowships. In 2012 Stephen returned to Australia to establish his own research group. Since 2016 Stephen has been Associate Professor of Statistical Genomics at the University of Melbourne. In 2016 Stephen was awarded the Woodward Medal by the University of Melbourne, the University’s highest award for research by faculty. In 2019 Stephen was awarded the Moran Medal of the Australian Academy of Science.
Stephen’s work covers several aspects of statistical and population genetics. His main interests are in detecting and controlling for population differences in genetic data; typing complex genetic variation, with a particular focus on immune-associated loci; and performing statistically rigorous analyses of the relationship of genetic variants to disease.
|Alistair Forrest, University of Western Australia, Perth
||Professor Alistair Forrest is an NHMRC senior research fellow and head of the systems biology and genomics lab at the Harry Perkins Institute of Medical Research in Western Australia. He is an expert in transcriptomics, and as scientific coordinator of FANTOM5, led the international consortium to globally map human promoters, enhancers, microRNAs and long non-coding RNAs using Cap Analysis of Gene Expression and RNA-seq. He researches broadly in the areas of genomics, transcriptomics and systems biology, and is interested in describing the biological components encoded in our genomes and how they work together in systems. His lab has two major research streams: single cell analysis of tumours (he leads the Western Australian cancer single cell consortium and the ACRF Centre for Advanced Cancer genomics); and mapping enhancers of known Mendelian disease genes and assessing their role in genetic disease. The common thread between these streams is application of genome wide measurements and integrative analysis.|
|Sarah Medland, QIMR, Brisbane||
Professor Sarah Medland is a statistical geneticist working on mental health and neurological traits. She received her PhD in 2006 from the University of Queensland, followed by a Sidney Sax NHMRC Post-doctoral Fellowship at the Virginia Institute of Psychiatric and Behavioral Genetics in USA. She is currently the coordinator of the mental health research program and head of the psychiatric genetics group at QIMR Berghofer Medical Research Institute. As chair of the genetics team of ENIGMA neuro-imaging genetics consortium, Sarah has played a leading role in large multi-site studies identifying genetic variants influencing brain structure in healthy and disease-focused cohorts. She is also the PI of nation-wide studies recruiting large cohorts of individuals diagnosed with ADHD, ASD, Bipolar, Depression and Schizophrenia which are seeking to identify genetic variants associated with developing these disorders and variation in treatment response.
Hope to see you there!
For general enquiries, please email firstname.lastname@example.org
2019 ORGANISING COMMITTEE
Co-convenor: Jan Fullerton (Neuroscience Research Australia)
Co-convenor: Carol Dobson-Stone (University of Sydney)
Co-convenor Joseph Powell (Garvan Institute)
Peter Schofield (Neuroscience Research Australia)
Marina Kennerson (ANZAC Research Institute & University of Sydney)
Irina Voineagu (University of New South Wales)
Georgia Chenevix-Trench (QIMR Berghofer Medical Research Institute)
Nick Martin (QIMR Berghofer Medical Research Institute)
Lyn Griffiths (Queensland University of Technology)
Stuart MacGregor (QIMR Berghofer Medical Research Institute)
David Evans (University of Queensland Diamantina Institute)
Melanie Bahlo (Walter and Eliza Hall Institute)
Justin Rubio (University of Melbourne)
Eric Moses (Curtin University & University of Western Australia)
Nicola Armstrong (Murdoch University)
Jac Charlesworth (University of Tasmania)
Alex Hewitt (University of Tasmania)
The NeuRA Sensation Movement Balance & Falls Research Theme regularly hosts specialised Sensorimotor Control Seminars. All Seminars start at 10am. Seminars are open to NeuRA staff and external collaborators.
|Date||Presenter||Group||Title / Theme|
|Feb 15||Jim Nuzzo||Taylor||Reproducibility of measures of muscle strength and voluntary activation.|
|Mar 1||Prof Betti Wollesen||Delbaere||Effects of a dual task managing intervention to improve walking performance of older adults|
|Mar 15||Ludovico Messineo||Eckert||Obstructive sleep apnoea predictors and therapeutic advancements|
|Mar 29||Paulo Pelicioni||Lord||Insights into the cortical control of balance during choice-stepping reaction time tasks: a functional near-infrared spectroscopy study|
|Apr 12||Marty Héroux||Gandevia||Perceiving what you grasp, and grasping what you perceive|
|May 3||Carlo Rinaudo||Migliaccio||Do sinusoidal gaze stabilising exercises result in adaptation of the high frequency head impulse vestibulo-ocular reflex?|
|May 10||Hanna Hensen||Eckert||Sleep apnoea in multiple sclerosis: Prevalence and pathophysiological traits|
|May 24||Lewis Ingram||Gandevia||Quantifying upper limb motor impairment in people with multiple sclerosis|
|June 7||Jasmine Menant||Lord||The contribution of visuo-spatial working memory for obstacle avoidance – preliminary findings|
|June 21||Adam Martinac||Bilston||Computational modelling of tracer movement in perivascular spaces|
|July 5||Nipuna Cooray||Brown||Developing a digital behaviour change intervention as a mobile app for parents to prevent fall-related injuries of infants|
|July 19||Matt Brodie||Lord||Neurorehabilitation in people with Parkinson’s disease: Early findings from the smart socks project|
|Aug 2||Bianca Albanese||Brown||Influence of child restraint design features on correct use|
|Aug 16||Aidan Cashin||McAuley||Current status and trends in low back pain research: a scoping review of the Physiotherapy Evidence Database|
|Aug 30||Isabella Epiu||Butler||Reflex responses to airway occlusion in inspiratory muscles in COPD and age-matched participants|
|Sept 13||ILP students||3 minute theses|
|Sept 27||Annie Butler||Gandevia||Perceptions of weight|
|Oct 11||Ben Tong||Eckert||Oral appliance therapy for obstructive sleep apnoea|
|Oct 25||Mae Lim||Delbaere||Health literacy and fear of falling|
|Nov 8||Lauriane Jugé||Bilston||Novel biomarkers to identify causes of brain ventricular dilation|
|Nov 22||Richard Lim||Eckert||Pharmacological targets for improved upper airway function in obstructive sleep apnoea|
|Dec 6||Christina Norris||Close||Care of older people in surgery|
NeuRA, Level 3 John and Betty Lynch Seminar Room
The NeuRA Invited Lecture series aims to attract leading national and international researchers from all fields of neuroscience. This series is open to all NeuRA staff and relevant external groups.
If you are from a relevant external group or individual and would like to sign up to Invited Series Seminar emails, please fill out the form.
|22nd of Feb||Prof Bernard Balleine||UNSW, Decision Neuroscience Lab||Interaction of the corticostriatal and thalamostriatal networks in goal-directed action|
|29th of Mar||Prof Nicola Lautenshlager||University of Melbourne||Physical activity for cognitive health: what can we tell older adults with subjective cognitive decline and mild cognitive impairment?|
|3rd of May||Prof Fernando Calamante||Director, Sydney Imaging, University of Sydney||Diffusion MRI fibre-tracking: a non-invasive window to the brain’s wiring|
|31st of May||Prof Steven Petrou||Director, The Florey Institute||Opportunities for intervention in rare neurogenetic disorders|
|21st of Jun||Dr Francesco Papaleo||Italian Institute of Technology, Genova, Italy||Perinatal oxytocin to ameliorate altered developmental trajectories in 22q11.2 Deletion Syndrome|
|26th of Jul||Prof Jacqui Close||Group Leader, NeuRA||TBC|
|30th of Aug||Prof Tom Johnstone||Director of Neuroimaging, School of Health Sciences, Swinburne University of Technology||TBC|
|27th of Sep||Prof Peter Catcheside||College of Medicine and Public Health, Flinders University||TBC|
|25th of Oct||Dr Ruth Peters||Group Leader, NeuRA||TBC|
|29th of Nov||A/Prof Erica Sloan||Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia; Semel Institute for Neuroscience & Jonsson Comprehensive Cancer Center, University of California Los Angeles||TBC|
Dr Ruth Peters (T: +612 9399 1015 E: email@example.com)
Dr Steve Kassem (T: +612 9399 1037 E: firstname.lastname@example.org)
NeuRA, Level 3 John and Betty Lynch Seminar Room